New Virus Linked to Colorectal Cancer
A recently identified virus hiding in common gut bacteria may be associated with colorectal cancer, according to a new study.
Researchers from Denmark published their findings in the journal Communications Medicine earlier this month, revealing that colorectal cancer patients are nearly twice as likely to harbor a previously unknown virus in Bacteroides fragilis, a bacterium typically found in the human intestines. This discovery could deepen our understanding of how the gut microbiome influences cancer development.
“These findings underscore the significance of the gut microbiome and its connection to our health,” commented Dr. Flemming Damgaard from Odense University Hospital and the University of Southern Denmark. “To grasp the complete picture, we must delve into the genetic material of these bacteria.”
For some time, the medical community has recognized that Bacteroides fragilis is frequently present in colorectal cancer patients. However, it’s also found in many healthy individuals, raising questions about its role in cancer progression. Researchers examined subtle genetic variations among these bacteria, leading to an unexpected discovery.
“We were taken aback to find the entire virus in the bacteria of colorectal cancer patients,” Damgaard mentioned, reflecting on the unexpected nature of the findings.
Identified as a bacteriophage, this virus targets bacteria rather than human cells. This particular type had not been documented before.
In their study, the team analyzed stool samples from 877 individuals across Europe, the U.S., and Asia, discovering that colorectal cancer patients showed a higher prevalence of the virus compared to those without cancer.
While the results suggest a strong correlation, researchers emphasize that these findings don’t definitively prove that the virus causes colorectal cancer, and caution that it’s premature to make definitive conclusions.
“A significant limitation is our uncertainty about why this virus is connected to colorectal cancer,” stated co-author Ulrik Stenz Justsen. “However, we are actively pursuing further research.” The team is now conducting lab and animal studies to determine if the virus influences bacterial activity in ways that could affect cancer risk.
Understanding microbial cells in the human body is still a puzzle, but their impact on human health is coming to light. “There’s a lot more to uncover in the realm of the human microbiome,” Damgaard noted.
The World Health Organization indicates that colorectal cancer remains a leading cause of cancer-related deaths globally. High-profile cases, such as those involving James van der Beek and other celebrities, have brought attention to the disease’s prevalence across different demographics.
While lifestyle and diet are significant risk factors for colorectal cancer, the potential influence of gut bacteria is garnering increased attention. Current screening methods involve colonoscopies and stool tests that check for hidden blood, but researchers hope future tests may include screening for viral markers like those identified in this study.
Researchers pointed to cervical cancer as an example where identifying viral causes has improved prevention, with HPV vaccinations helping to lower new infections linked to cervical cancer. If a viral role in colorectal cancer is confirmed, a similar path may be possible, though researchers caution that it’s too soon for certainty.
“It’s early days to take action,” Damgaard concluded, expressing hope for the future. “We want to inspire that hope in others, too.”
